Roche’s skin cancer drug Erivedge pulled from CDF

13th October 2017 Uncategorised 0

Roche’s Erivedge could be removed from the Cancer Drugs Fund within months after the National Institute for Health and Care Excellence ruled that the drug was not a cost-effective treatment for skin cancer.

More: Roche’s skin cancer drug Erivedge pulled from CDF
Source: News